TY  - GEN 
AU  - Gutiérrez Rojas, Luis
AU  - García Jiménez, Jesús
PY  - 2024
UR  - https://hdl.handle.net/10481/110352
AB  - Background: Treatment-resistant depression (TRD) is defined as the failure of at least two antidepressants in adequate doses and timing during a major depressive episode. Esketamine intranasal (ESK-IN) has been approved by the Food and Drug...
LA  - eng
PB  - Sage Journal
KW  - Intranasal esketamine
KW  - Treatment-resistant depression
KW  - Compassionate use
TI  - Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment
DO  - 10.1177/02698811241267837
ER  -